Modernizing Opioid Treatment Access Act 2.0 of 2026 expands access to methadone for opioid use disorder through pharmacies.
Modernizing Opioid Treatment Access Act 2.0 of 2026 amends the Controlled Substances Act to allow pharmacies to dispense methadone for opioid use disorder without requiring a separate registration. It waives certain requirements for practitioners who prescribe methadone, including addiction medicine physicians and psychiatrists with specific board certifications. The bill mandates informed consent for patients and requires the Attorney General to register qualified practitioners.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
Analyze for Free
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.